Aprea Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
APRE
CUSIP
03836J201
Type
Equity
Class
COM NEW
Num filings
22
Total reported value, excl. options
$3.66 M
Manager Report Date Value ($000) Shares Option Type